Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Corcept Therapeutics Inc (NASDAQ:CORT)

5.28
Delayed Data
As of May 23
 -0.07 / -1.31%
Today’s Change
3.22
Today|||52-Week Range
7.67
+6.02%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues12.0M13.3M15.0M16.1M
 
 
 
 
 
Cost of Goods Sold382.0K226.0K336.0K376.0K
 
 
 
 
 
Depreciation And Amortization57.0K30.0K28.0K27.0K
 
 
 
 
 
 
Operating ExpensesGross Income11.5M13.0M14.6M15.7M
 
 
 
 
 
General Expenses12.7M12.9M13.0M15.1M
 
 
 
 
 
Research And Development3.3M3.6M4.1M4.6M
 
 
 
 
 
Total Operating Expenses13.1M13.2M13.3M15.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.2M102.0K1.7M592.0K
 
 
 
 
 
Interest Expense On Debt737.0K698.0K600.0K584.0K
 
 
 
 
 
Other Expenses-33.0K-5.0K-92.0K-27.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.9M-601.0K959.0K-19.0K
 
 
 
 
 
Net Income-1.9M-601.0K959.0K-19.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS107.9M108.5M109.2M109.7M
 
 
 
 
 
Shares To Calculate EPS Diluted107.9M108.5M113.8M109.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.02-$0.01$0.01$0.00
 
 
 
 
EPS Diluted-$0.02-$0.01$0.01-$0.00